Riverbridge Partners LLC Sells 231,077 Shares of Exponent, Inc. (NASDAQ:EXPO)

Riverbridge Partners LLC decreased its position in Exponent, Inc. (NASDAQ:EXPOFree Report) by 26.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 652,715 shares of the business services provider’s stock after selling 231,077 shares during the quarter. Riverbridge Partners LLC owned about 1.29% of Exponent worth $58,157,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Mitchell & Pahl Private Wealth LLC increased its position in Exponent by 9.8% during the 4th quarter. Mitchell & Pahl Private Wealth LLC now owns 6,545 shares of the business services provider’s stock worth $583,000 after buying an additional 584 shares during the period. Trust Co. of Vermont acquired a new stake in Exponent in the 4th quarter worth about $45,000. Empirical Asset Management LLC bought a new stake in Exponent in the 4th quarter valued at about $234,000. Heritage Family Offices LLP grew its position in shares of Exponent by 3.8% during the 4th quarter. Heritage Family Offices LLP now owns 3,123 shares of the business services provider’s stock worth $278,000 after purchasing an additional 114 shares in the last quarter. Finally, Argent Capital Management LLC increased its holdings in shares of Exponent by 17.3% during the fourth quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider’s stock worth $2,524,000 after purchasing an additional 4,173 shares during the period. Institutional investors own 92.37% of the company’s stock.

Exponent Price Performance

Exponent stock opened at $92.94 on Thursday. The firm has a market cap of $4.72 billion, a PE ratio of 44.90 and a beta of 0.71. The stock’s fifty day moving average price is $93.33 and its two-hundred day moving average price is $101.46. Exponent, Inc. has a one year low of $68.70 and a one year high of $115.75.

Insider Buying and Selling at Exponent

In other news, Director Carol Lindstrom sold 1,039 shares of the stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the completion of the transaction, the director now owns 5,871 shares of the company’s stock, valued at approximately $565,494.72. This represents a 15.04 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Paul R. Johnston sold 14,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the completion of the sale, the director now owns 80,742 shares in the company, valued at approximately $8,445,613.20. The trade was a 14.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 30,339 shares of company stock valued at $3,103,065 in the last ninety days. 2.10% of the stock is currently owned by company insiders.

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Stories

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.